|
US7994298B2
(en)
|
2004-09-24 |
2011-08-09 |
Trustees Of Dartmouth College |
Chimeric NK receptor and methods for treating cancer
|
|
CN103555733A
(zh)
|
2005-01-05 |
2014-02-05 |
F-星生物技术研究与开发有限公司 |
分子中互补决定区以外的区域中工程改造了的具有结合特性的合成免疫球蛋白结构域
|
|
AU2008211227B2
(en)
†
|
2007-01-30 |
2014-04-17 |
Epivax, Inc. |
Regulatory T cell epitopes, compositions and uses thereof
|
|
US20100297093A1
(en)
*
|
2007-09-25 |
2010-11-25 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human |
Modified t cell receptors and related materials and methods
|
|
US9493578B2
(en)
|
2009-09-02 |
2016-11-15 |
Xencor, Inc. |
Compositions and methods for simultaneous bivalent and monovalent co-engagement of antigens
|
|
WO2011059836A2
(en)
|
2009-10-29 |
2011-05-19 |
Trustees Of Dartmouth College |
T cell receptor-deficient t cell compositions
|
|
US9273283B2
(en)
|
2009-10-29 |
2016-03-01 |
The Trustees Of Dartmouth College |
Method of producing T cell receptor-deficient T cells expressing a chimeric receptor
|
|
US12492376B2
(en)
|
2009-10-29 |
2025-12-09 |
The Trustees Of Dartmouth College |
T-cell receptor-deficient T cell compositions
|
|
EP3029066B1
(en)
|
2010-07-29 |
2019-02-20 |
Xencor, Inc. |
Antibodies with modified isoelectric points
|
|
US9833476B2
(en)
|
2011-08-31 |
2017-12-05 |
The Trustees Of Dartmouth College |
NKP30 receptor targeted therapeutics
|
|
US12466897B2
(en)
|
2011-10-10 |
2025-11-11 |
Xencor, Inc. |
Heterodimeric human IgG1 polypeptides with isoelectric point modifications
|
|
US10851178B2
(en)
|
2011-10-10 |
2020-12-01 |
Xencor, Inc. |
Heterodimeric human IgG1 polypeptides with isoelectric point modifications
|
|
ES2719495T5
(en)
|
2012-05-07 |
2025-09-10 |
Dartmouth College |
Anti-b7-h6 antibody, fusion proteins, and methods of using the same
|
|
AU2013295652B2
(en)
*
|
2012-07-27 |
2018-02-08 |
The Board Of Trustees Of The University Of Illinois |
Engineering T-cell receptors
|
|
US10713726B1
(en)
|
2013-01-13 |
2020-07-14 |
United Services Automobile Association (Usaa) |
Determining insurance policy modifications using informatic sensor data
|
|
US10131710B2
(en)
|
2013-01-14 |
2018-11-20 |
Xencor, Inc. |
Optimized antibody variable regions
|
|
CA2898100C
(en)
|
2013-01-14 |
2023-10-10 |
Xencor, Inc. |
Novel heterodimeric proteins
|
|
US10968276B2
(en)
|
2013-03-12 |
2021-04-06 |
Xencor, Inc. |
Optimized anti-CD3 variable regions
|
|
US11053316B2
(en)
|
2013-01-14 |
2021-07-06 |
Xencor, Inc. |
Optimized antibody variable regions
|
|
US10487155B2
(en)
|
2013-01-14 |
2019-11-26 |
Xencor, Inc. |
Heterodimeric proteins
|
|
US9701759B2
(en)
|
2013-01-14 |
2017-07-11 |
Xencor, Inc. |
Heterodimeric proteins
|
|
US9605084B2
(en)
|
2013-03-15 |
2017-03-28 |
Xencor, Inc. |
Heterodimeric proteins
|
|
US9738722B2
(en)
|
2013-01-15 |
2017-08-22 |
Xencor, Inc. |
Rapid clearance of antigen complexes using novel antibodies
|
|
EP4303232A3
(en)
|
2013-02-15 |
2024-04-17 |
The Regents of The University of California |
Chimeric antigen receptor and methods of use thereof
|
|
EP2971288A4
(en)
*
|
2013-03-14 |
2016-12-07 |
Elwha Llc |
COMPOSITIONS, METHODS AND COMPUTER SYSTEMS FOR THE MANUFACTURE AND ADMINISTRATION OF MODIFIED T CELLS
|
|
US9587237B2
(en)
|
2013-03-14 |
2017-03-07 |
Elwha Llc |
Compositions, methods, and computer systems related to making and administering modified T cells
|
|
US9499855B2
(en)
|
2013-03-14 |
2016-11-22 |
Elwha Llc |
Compositions, methods, and computer systems related to making and administering modified T cells
|
|
EP2970486B1
(en)
|
2013-03-15 |
2018-05-16 |
Xencor, Inc. |
Modulation of t cells with bispecific antibodies and fc fusions
|
|
US10519242B2
(en)
|
2013-03-15 |
2019-12-31 |
Xencor, Inc. |
Targeting regulatory T cells with heterodimeric proteins
|
|
US10106624B2
(en)
|
2013-03-15 |
2018-10-23 |
Xencor, Inc. |
Heterodimeric proteins
|
|
US10858417B2
(en)
|
2013-03-15 |
2020-12-08 |
Xencor, Inc. |
Heterodimeric proteins
|
|
WO2014201319A1
(en)
*
|
2013-06-14 |
2014-12-18 |
The University Of Houston System |
Targeting tumor neovasculature with modified chimeric antigen receptors
|
|
TWI707038B
(zh)
|
2013-08-05 |
2020-10-11 |
美商扭轉生物科技有限公司 |
重新合成之基因庫
|
|
US9947051B1
(en)
|
2013-08-16 |
2018-04-17 |
United Services Automobile Association |
Identifying and recommending insurance policy products/services using informatic sensor data
|
|
GB201317929D0
(en)
*
|
2013-10-10 |
2013-11-27 |
Ucl Business Plc |
Chimeric antigen receptor
|
|
EP3071594A4
(en)
|
2013-11-22 |
2017-05-03 |
The Board of Trustees of the University of Illionis |
Engineered high-affinity human t cell receptors
|
|
US10552911B1
(en)
|
2014-01-10 |
2020-02-04 |
United Services Automobile Association (Usaa) |
Determining status of building modifications using informatics sensor data
|
|
US11416941B1
(en)
|
2014-01-10 |
2022-08-16 |
United Services Automobile Association (Usaa) |
Electronic sensor management
|
|
US11087404B1
(en)
|
2014-01-10 |
2021-08-10 |
United Services Automobile Association (Usaa) |
Electronic sensor management
|
|
US12100050B1
(en)
|
2014-01-10 |
2024-09-24 |
United Services Automobile Association (Usaa) |
Electronic sensor management
|
|
US11847666B1
(en)
|
2014-02-24 |
2023-12-19 |
United Services Automobile Association (Usaa) |
Determining status of building modifications using informatics sensor data
|
|
JP6556156B2
(ja)
|
2014-02-27 |
2019-08-07 |
ユーシーエル ビジネス ピーエルシー |
Aprilバリアント
|
|
US10614525B1
(en)
|
2014-03-05 |
2020-04-07 |
United Services Automobile Association (Usaa) |
Utilizing credit and informatic data for insurance underwriting purposes
|
|
JP6775422B2
(ja)
|
2014-03-28 |
2020-10-28 |
ゼンコー・インコーポレイテッドXencor、 Inc. |
Cd38及びcd3に結合する二重特異性抗体
|
|
WO2016014725A1
(en)
|
2014-07-22 |
2016-01-28 |
The University Of Notre Dame Du Lac |
Molecular constructs and uses thereof
|
|
BR112017011166A2
(pt)
|
2014-11-26 |
2018-02-27 |
Xencor, Inc. |
anticorpos heterodiméricos que se ligam a cd3 e cd38
|
|
CN110894240B
(zh)
|
2014-11-26 |
2022-04-15 |
森科股份有限公司 |
结合cd3和肿瘤抗原的异二聚体抗体
|
|
US10259887B2
(en)
|
2014-11-26 |
2019-04-16 |
Xencor, Inc. |
Heterodimeric antibodies that bind CD3 and tumor antigens
|
|
WO2016105450A2
(en)
|
2014-12-22 |
2016-06-30 |
Xencor, Inc. |
Trispecific antibodies
|
|
WO2016126882A1
(en)
|
2015-02-04 |
2016-08-11 |
Twist Bioscience Corporation |
Methods and devices for de novo oligonucleic acid assembly
|
|
WO2016141387A1
(en)
|
2015-03-05 |
2016-09-09 |
Xencor, Inc. |
Modulation of t cells with bispecific antibodies and fc fusions
|
|
US9981239B2
(en)
|
2015-04-21 |
2018-05-29 |
Twist Bioscience Corporation |
Devices and methods for oligonucleic acid library synthesis
|
|
CN107995913B
(zh)
|
2015-05-18 |
2022-02-11 |
T细胞受体治疗公司 |
使用融合蛋白对tcr重编程的组合物和方法
|
|
KR20180050411A
(ko)
|
2015-09-18 |
2018-05-14 |
트위스트 바이오사이언스 코포레이션 |
올리고핵산 변이체 라이브러리 및 그의 합성
|
|
KR102794025B1
(ko)
|
2015-09-22 |
2025-04-09 |
트위스트 바이오사이언스 코포레이션 |
핵산 합성을 위한 가요성 기판
|
|
EP3377523A4
(en)
*
|
2015-11-19 |
2019-06-19 |
The Regents of The University of California |
CONDITIONALLY REPRIMATABLE IMMUNOCELL RECEPTORS AND METHOD FOR USE THEREOF
|
|
CN115920796A
(zh)
|
2015-12-01 |
2023-04-07 |
特韦斯特生物科学公司 |
功能化表面及其制备
|
|
JP7058219B2
(ja)
|
2015-12-07 |
2022-04-21 |
ゼンコア インコーポレイテッド |
Cd3及びpsmaに結合するヘテロ二量体抗体
|
|
JP7068169B2
(ja)
|
2016-01-08 |
2022-05-16 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
条件付活性ヘテロ二量体ポリペプチド及びその使用方法
|
|
RU2021107053A
(ru)
*
|
2016-03-16 |
2021-08-24 |
Нексиммьюн, Инк. |
Получение антигенспецифических t-клеток
|
|
SI3468586T1
(sl)
|
2016-06-14 |
2025-01-31 |
Xencor, Inc. |
Bispecifična protitelesa za zaviralce kontrolnih točk
|
|
WO2018005706A1
(en)
|
2016-06-28 |
2018-01-04 |
Xencor, Inc. |
Heterodimeric antibodies that bind somatostatin receptor 2
|
|
EP3494138A1
(en)
|
2016-08-02 |
2019-06-12 |
TCR2 Therapeutics Inc. |
Compositions and methods for tcr reprogramming using fusion proteins
|
|
JP6854340B2
(ja)
|
2016-08-22 |
2021-04-07 |
ツイスト バイオサイエンス コーポレーション |
デノボ合成された核酸ライブラリ
|
|
US10793632B2
(en)
|
2016-08-30 |
2020-10-06 |
Xencor, Inc. |
Bispecific immunomodulatory antibodies that bind costimulatory and checkpoint receptors
|
|
US10417457B2
(en)
|
2016-09-21 |
2019-09-17 |
Twist Bioscience Corporation |
Nucleic acid based data storage
|
|
CA3036745A1
(en)
|
2016-10-07 |
2018-04-12 |
TCR2 Therapeutics Inc. |
Compositions and methods for t-cell receptors reprogramming using fusion proteins
|
|
CN110214147A
(zh)
|
2016-10-14 |
2019-09-06 |
Xencor股份有限公司 |
IL15/IL15Rα异源二聚体FC-融合蛋白
|
|
US11851491B2
(en)
|
2016-11-22 |
2023-12-26 |
TCR2 Therapeutics Inc. |
Compositions and methods for TCR reprogramming using fusion proteins
|
|
KR102514213B1
(ko)
*
|
2016-12-16 |
2023-03-27 |
트위스트 바이오사이언스 코포레이션 |
면역 시냅스의 변이체 라이브러리 및 그의 합성
|
|
BR112019016989A2
(pt)
|
2017-02-17 |
2020-05-26 |
Denali Therapeutics Inc. |
Polipeptídeos de ligação ao receptor de transferrina manipulados
|
|
CN110892485B
(zh)
|
2017-02-22 |
2024-03-22 |
特韦斯特生物科学公司 |
基于核酸的数据存储
|
|
WO2018170169A1
(en)
|
2017-03-15 |
2018-09-20 |
Twist Bioscience Corporation |
Variant libraries of the immunological synapse and synthesis thereof
|
|
US10696965B2
(en)
|
2017-06-12 |
2020-06-30 |
Twist Bioscience Corporation |
Methods for seamless nucleic acid assembly
|
|
WO2018231864A1
(en)
|
2017-06-12 |
2018-12-20 |
Twist Bioscience Corporation |
Methods for seamless nucleic acid assembly
|
|
US11084863B2
(en)
|
2017-06-30 |
2021-08-10 |
Xencor, Inc. |
Targeted heterodimeric Fc fusion proteins containing IL-15 IL-15alpha and antigen binding domains
|
|
SG11202000025SA
(en)
|
2017-07-14 |
2020-02-27 |
Immatics Biotechnologies Gmbh |
Improved dual specificity polypeptide molecule
|
|
CN111566125A
(zh)
|
2017-09-11 |
2020-08-21 |
特韦斯特生物科学公司 |
Gpcr结合蛋白及其合成
|
|
CN111565834B
(zh)
|
2017-10-20 |
2022-08-26 |
特韦斯特生物科学公司 |
用于多核苷酸合成的加热的纳米孔
|
|
JP2021502100A
(ja)
|
2017-11-08 |
2021-01-28 |
ゼンコア インコーポレイテッド |
新規抗pd−1配列を用いた二重特異性および単一特異性抗体
|
|
US10981992B2
(en)
|
2017-11-08 |
2021-04-20 |
Xencor, Inc. |
Bispecific immunomodulatory antibodies that bind costimulatory and checkpoint receptors
|
|
US11319355B2
(en)
|
2017-12-19 |
2022-05-03 |
Xencor, Inc. |
Engineered IL-2 Fc fusion proteins
|
|
KR102804057B1
(ko)
|
2018-01-04 |
2025-05-07 |
트위스트 바이오사이언스 코포레이션 |
Dna 기반 디지털 정보 저장
|
|
WO2019195623A2
(en)
|
2018-04-04 |
2019-10-10 |
Xencor, Inc. |
Heterodimeric antibodies that bind fibroblast activation protein
|
|
US11505595B2
(en)
|
2018-04-18 |
2022-11-22 |
Xencor, Inc. |
TIM-3 targeted heterodimeric fusion proteins containing IL-15/IL-15RA Fc-fusion proteins and TIM-3 antigen binding domains
|
|
SG11202010163QA
(en)
|
2018-04-18 |
2020-11-27 |
Xencor Inc |
Pd-1 targeted heterodimeric fusion proteins containing il-15/il-15ra fc-fusion proteins and pd-1 antigen binding domains and uses thereof
|
|
CA3100739A1
(en)
|
2018-05-18 |
2019-11-21 |
Twist Bioscience Corporation |
Polynucleotides, reagents, and methods for nucleic acid hybridization
|
|
EP3827263A1
(en)
|
2018-07-26 |
2021-06-02 |
Frame Pharmaceuticals B.V. |
Cancer vaccines for colorectal cancer
|
|
WO2020022901A1
(en)
|
2018-07-26 |
2020-01-30 |
Frame Pharmaceuticals B.V. |
Cancer vaccines for uterine cancer
|
|
CA3106567A1
(en)
|
2018-07-26 |
2020-01-30 |
Frame Pharmaceuticals B.V. |
Cancer vaccines for kidney cancer
|
|
CA3106574A1
(en)
|
2018-07-26 |
2020-01-30 |
Frame Pharmaceuticals B.V. |
Arid1a, cdkn2a, kmt2b, kmt2d, tp53 and pten vaccines for cancer
|
|
WO2020022899A1
(en)
|
2018-07-26 |
2020-01-30 |
Frame Pharmaceuticals B.V. |
Cancer vaccines for breast cancer
|
|
EP3861016A2
(en)
|
2018-10-03 |
2021-08-11 |
Xencor, Inc. |
Il-12 heterodimeric fc-fusion proteins
|
|
US12466892B2
(en)
|
2018-11-08 |
2025-11-11 |
The Regents Of The University Of California |
Systems and methods for targeting cancer cells
|
|
US12357959B2
(en)
|
2018-12-26 |
2025-07-15 |
Twist Bioscience Corporation |
Highly accurate de novo polynucleotide synthesis
|
|
CA3131691A1
(en)
|
2019-02-26 |
2020-09-03 |
Twist Bioscience Corporation |
Variant nucleic acid libraries for antibody optimization
|
|
CN113766930B
(zh)
|
2019-02-26 |
2025-07-22 |
特韦斯特生物科学公司 |
Glp1受体的变异核酸文库
|
|
UA128825C2
(uk)
|
2019-03-01 |
2024-10-30 |
Ксенкор, Інк. |
Гетеродимерні антитіла, що зв'язують enpp3 та cd3
|
|
AU2020298294A1
(en)
|
2019-06-21 |
2022-02-17 |
Twist Bioscience Corporation |
Barcode-based nucleic acid sequence assembly
|
|
WO2021061842A1
(en)
|
2019-09-23 |
2021-04-01 |
Twist Bioscience Corporation |
Variant nucleic acid libraries for single domain antibodies
|
|
JP2022548309A
(ja)
|
2019-09-23 |
2022-11-17 |
ツイスト バイオサイエンス コーポレーション |
Crth2のバリアント核酸ライブラリー
|
|
IL293670A
(en)
|
2019-12-09 |
2022-08-01 |
Twist Bioscience Corp |
Variable nucleic acid libraries for adenosine receptors
|
|
WO2021231976A1
(en)
|
2020-05-14 |
2021-11-18 |
Xencor, Inc. |
Heterodimeric antibodies that bind prostate specific membrane antigen (psma) and cd3
|
|
CA3192204A1
(en)
|
2020-08-19 |
2022-02-24 |
Xencor, Inc. |
Anti-cd28 and/or anti-b7h3 compositions
|
|
JP2024511319A
(ja)
|
2021-03-09 |
2024-03-13 |
ゼンコア インコーポレイテッド |
Cd3及びcldn6に結合するヘテロ二量体抗体
|
|
JP2024509274A
(ja)
|
2021-03-10 |
2024-02-29 |
ゼンコア インコーポレイテッド |
Cd3及びgpc3に結合するヘテロ二量体抗体
|
|
EP4334361A1
(en)
|
2021-05-05 |
2024-03-13 |
Immatics Biotechnologies GmbH |
Antigen binding proteins specifically binding prame
|
|
GB202113673D0
(en)
*
|
2021-09-24 |
2021-11-10 |
Reflection Therapeutics Ltd |
Targeted cell therapies
|